Emerging role of liver X receptors in cardiac pathophysiology and heart failure

Megan V. Cannon, Wiek H. van Gilst, Rudolf A. de Boer*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

50 Citations (Scopus)
8 Downloads (Pure)

Abstract

Liver X receptors (LXRs) are master regulators of metabolism and have been studied for their pharmacological potential in vascular and metabolic disease. Besides their established role in metabolic homeostasis and disease, there is mounting evidence to suggest that LXRs may exert direct beneficial effects in the heart. Here, we aim to provide a conceptual framework to explain the broad mode of action of LXRs and how LXR signaling may be an important local and systemic target for the treatment of heart failure. We discuss the potential role of LXRs in systemic conditions associated with heart failure, such as hypertension, diabetes, and renal and vascular disease. Further, we expound on recent data that implicate a direct role for LXR activation in the heart, for its impact on cardiomyocyte damage and loss due to ischemia, and effects on cardiac hypertrophy, fibrosis, and myocardial metabolism. Taken together, the accumulating evidence supports the notion that LXRs may represent a novel therapeutic target for the treatment of heart failure.

Original languageEnglish
Article number3
Pages (from-to)1-17
Number of pages17
JournalBasic Research in Cardiology
Volume111
Issue number1
DOIs
Publication statusPublished - 26 Nov 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015, The Author(s).

Fingerprint

Dive into the research topics of 'Emerging role of liver X receptors in cardiac pathophysiology and heart failure'. Together they form a unique fingerprint.

Cite this